Assessment of cardiac ischaemia and viability: Role of cardiovascular magnetic resonance

European Heart Journal

Volumn 32, Issue 7, 2011, Pages 799-809

  Schwitter, Juerg ^a   Arai, Andrew E ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Acute coronary syndrome; Cardiovascular magnetic resonance; Computed tomography; Congestive heart failure; Coronary artery disease; Echocardiography; Myocardial infarction; Single photon emission computed tomography

Indexed keywords

ATROPINE; DOBUTAMINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BLEEDING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL RESEARCH; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; EDEMA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INFARCTION; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SCINTIGRAPHY; ST SEGMENT ELEVATION; STRESS; THORAX PAIN;

CARDIOTONIC AGENTS; CHRONIC DISEASE; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; DOBUTAMINE; FEASIBILITY STUDIES; HEART FAILURE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATIENT SAFETY; PROGNOSIS;

EID: 79953694796     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq481     Document Type: Review

References (149)

1. Fox K, Garcia M, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K. Guidelines on the management of stable angina pectoris. Eur Heart J 2006; doi: 10.1093/eurheartj/ehl002.
2. Heart disease and stroke statistics: update 2009. Circulation 2009;119:e1-e161.
3. Schwitter J. Myocardial perfusion in ischemic heart disease. In: Higgins CB, de Roos A, eds. MRI and CT of the Cardiovascular System. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.
4. Schwitter J. Myocardial perfusion. J Magn Reson Imaging 2006;24:953-963. (Pubitemid 44658230)
5. Schwitter J, ed. CMR Update. 1st ed. Zurich: J. Schwitter; 2008. p1-240. www. herz-mri.ch.
6. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, von Schulthess GK. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235. (Pubitemid 32433710)
7. Plein S, Radjenovic A, Ridgway JP, Barmby D, Greenwood JP, Ball SG, Sivananthan MU. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 2005;235: 423-430. (Pubitemid 40571077)
8. Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, Nagel E. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004;110: 835-842. (Pubitemid 39096012)
9. Plein S, Kozerke S, Suerder D, Luescher TF, Greenwood JP, Boesiger P, Schwitter J. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J 2008;29: 2148-2155.
10. Schwitter J, Wacker C, van Rossum A, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HB, Flamm S, Marquardt M, Johansson L. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-489. (Pubitemid 351264187)
11. Bertschinger KM, Nanz D, Buechi M, Luescher TF, Marincek B, von Schulthess GK, Schwitter J. Magnetic resonance myocardial first-pass perfusion imaging: parameter optimization for signal response and cardiac coverage. J Magn Reson Imaging 2001;14:556-562. (Pubitemid 33029541)
12. Giang T, Nanz D, Coulden R, Friedrich M, Graves M, Al-Saadi N, Lüscher T, von Schulthess G, Schwitter J. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multicenter experience. Eur Heart J 2004;25:1657-1665. (Pubitemid 39209287)
13. Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-1383. (Pubitemid 30169858)
14. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-437. (Pubitemid 36935536)
15. Ishida N, Sakuma H, Motoyasu M, Okinaka T, Isaka N, Nakano T, Takeda K. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003;229:209-216. (Pubitemid 37152126)
16. Kitagawa K, Sakuma H, Nagata M, Okuda S, Hirano M, Tanimoto A, Matsusako M, Lima JA, Kuribayashi S, Takeda K. Diagnostic accuracy of stress myocardial perfusion MRI and late gadolinium-enhanced MRI for detecting flowlimiting coronary artery disease: a multicenter study. Eur Radiol 2008;18: 2808-2816.
17. Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H, Groch MW, Mahmarian JJ. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999;99:2742-2749. (Pubitemid 29250019)
18. Van Train KF, Garcia EV, Maddahi J, Areeda J, Cooke CD, Kiat H, Silagan G, Folks R, Friedman J, Matzer L, Germano G, Bateman T, Ziffer J, DePuey E, Fink-Bennett D, Cloninger K, Berman D. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 1994;35:609-618. (Pubitemid 24114559)
19. He ZX, Iskandrian AS, Gupta NC, Verani MS. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial. J Nuc Med 1997;38:44-48. (Pubitemid 27026995)
20. Zaret BL, Rigo P, Wackers FJ, Hendel RC, Braat SH, Iskandrian AS, Sridhara BS, Jain D, Itti R, Serafini AN, Goris M, Lahiri A. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995;91:313-319.
21. Syed MA, Paterson DI, Ingkanisorn WP, Rhoads KL, Hill J, Cannon RO 3rd, Arai AE. Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research. J Cardiovasc Magn Reson 2005;7:763-768. (Pubitemid 41770053)
22. Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I. Prognostic value of cardiac magnetic resonance stress tests: Adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115: 1769-1776. (Pubitemid 46648614)
23. Paetsch I, Jahnke C, Ferrari VA, Rademakers FE, Pellikka PA, Hundley WG, Poldermans D, Bax JJ, Wegscheider K, Fleck E, Nagel E. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 2006; 27:1459-1464. (Pubitemid 43998080)
24. Plein S, Schwitter J, Suerder D, Greenwood J, Boesiger P, Kozerke S. k-t SENSE-accelerated myocardial perfusion MR imaging at 3.0 Tesla-comparison with 1.5 Tesla. Radiology 2008;249:493-500.
25. Wagner A, Bruder O, Schneider S, Nothnagel D, Buser P, Pons-Lado G, Dill T, Hombach V, Lombardi M, van Rossum A, Schwitter J, Senges J, Sabin S, Sechtem U, Mahrholdt H, Nagel E. Current variables, definitions and endpoints of the European Cardiovascular Magnetic Resonance Registry. J Cardiovasc Magn Reson 2009;11:43-55.
26. Cerqueira M, Verani M, Schwaiger M, Heo J, Iskandrian A. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994;23:384-389. (Pubitemid 24049369)
27. Belardinelli L, Linden J, Berne R. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97. (Pubitemid 19175413)
28. Mahmarian JJ, Cerqueira M, Iskandrian AE, Bateman T, Thomas G, Hendel RC. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the advance MPI 2 trial. J Am Coll Cardiol 2009;2:959-968.
29. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770. (Pubitemid 29083016)
30. Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, Kitzman DW, Little WC, Link KM. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999;100: 1697-1702. (Pubitemid 29485251)
31. Schalla S, Klein C, Paetsch I, Lehmkuhl H, Bornstedt A, Schnackenburg B, Fleck E, Nagel E. Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology 2002;224:845-851. (Pubitemid 34919823)
32. Rerkpattanapipat P, Gandhi SK, Darty SN, Williams RT, Davis AD, Mazur W, Clark HP, Little WC, Link KM, Hamilton CA, Hundley WG. Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol 2003;92:603-606. (Pubitemid 37013419)
33. Jahnke C, Paetsch I, Gebker R, Bornstedt A, Fleck E, Nagel E. Accelerated 4D dobutamine stress MR imaging with k-t BLAST: feasibility and diagnostic performance. Radiology 2006;241:718-728. (Pubitemid 46190537)
34. Gebker R, Jahnke C, Hucko T, Manka R, Mirelis JG, Hamdan A, Schnackenburg B, Fleck E, Paetsch I. Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease in women. Heart 2010;96:616-620.
35. Wahl A, Paetsch I, Gollesch A, Roethemeyer S, Foell D, Gebker R, Langreck H, Klein C, Fleck E, Nagel E. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J 2004;25:1230-1236. (Pubitemid 38891573)
36. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002;106:2328-2333. (Pubitemid 35244733)
37. Davies R, Goldberg D, Forman S, Pepine C, Knatterud G, Geller N, Sopko G, Pratt C, Deanfield J, Conti C. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043. (Pubitemid 27184271)
38. Wijns W, Kolh P, Danchin N, CarloDi M, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli M, Pirlet C, Pomar JL, Reifart N, Ribichini F, Schalij M, Sergeant P, Serruys P, Silber S, Uva M, Taggart D. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; doi:10.1093/eurheartj/ehq1277.
39. Diamond G, Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350-1358. (Pubitemid 9198112)
40. Ladenheim M, Pollock B, Rozanski A, Berman DS, Staniloff H, Forrester J, Diamond G. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-471. (Pubitemid 16164371)
41. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico J, Friedman J, Diamond G. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996;93:905-914.
42. Hachamovitch R, Berman DS, Shaw L, Kiat H, Cohen I, Cabico J, Friedman J, Diamond G. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-543. (Pubitemid 28090682)
43. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998; 32:57-62. (Pubitemid 28351042)
44. Steel K, Broderick R, Gandla V, Larose E, Resnic F, Jerosch-Herold M, Brown K, Kwong RY. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009; 120:1390-1400.
45. Maehara A, Mintz G, Bui A,Walter O, Castagna M, Canos D, Pichard A, Satler L, Waksman R, Suddath W, Laird J, Kent K, Weissman N. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40:904-910. (Pubitemid 35000496)
46. Burke A, Kolodgie F, Farb A, Weber D, Malcom G, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-940. (Pubitemid 32183797)
47. Ojio S, Takatsu H, Tanaka T. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000;102:2063-2069.
48. Kemp H, Kronmal R, Vlietstra R, Frye R. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986;7:479-483. (Pubitemid 16164373)
49. Bruschke AV, Kramer JR Jr, Bal ET, Haque IU, Detrano RC, Goormastic M. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J 1989;117:296-305. (Pubitemid 19059776)
50. Waters D, Lesperance J, Francetich M, Causey D, Theroux P, Chiang YK, Hudon G, Lemarbre L, Reitman M, Joyal M, Gosselin G, Dyrda I, Macer J, Havel RA. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990;82: 1940-1953.
51. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman J, Shaw L. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823-829. (Pubitemid 34174922)
52. Smith SJ, Feldman T, Hirshfeld JJ, Jacobs A, Kern M, King S III, Morrison D, O'Neill W, Schaff H, Whitlow P, Williams D. ACC/AHA/SCAI 2005 guidelines update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-e286.
53. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead C, Schubauer-Berigan M, Yoshimura T, Berman F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn Y-O, Amoros E, Ashmore P, Auvinen A, Bae J-M, Bernar Solano J, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklof M, Engels H, Engholm G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce M, Richardson D, Dodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. Br Med J 2005;331:77-82.
54. Biological effects of ionizing radiation (BEIR) reports VII-Phase 2. National Research Council. www.nap.edu/catalog/11340.html.
55. Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum A, Wagner A, Schwitter J, Senges J, Sabin G, Sechtem U, Mahrholdt H. EuroCMR (European Cardiovascular Magnetic Resonance) Registry. J Am Coll Cardiol 2009;54:1457-1466.
56. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filipatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008; 29:2909-2945.
57. Ricciardi M, Wu E, Davidson C, Choi K, Klocke F, Bonow R, Judd R, Kim R. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103: 2780-2783. (Pubitemid 32550063)
58. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379. (Pubitemid 36164969)
59. Simonetti O, Kim R, Fieno D, Hillenbrand HB, Wu E, Bundy JJ, Judd R. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223. (Pubitemid 32151298)
60. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100: 1992-2002. (Pubitemid 29529292)
61. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-1683.
62. Lima J, Judd R, Bazille A, Schulman S, Atalar E, Zerhouni E. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: Potential mechanisms. Circulation 1995;92:1117-1125.
63. Schwitter J, Saeed M,Wendland MF, Derugin N, Canet E, Brasch RC, Higgins CB. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997;30:1086-1094. (Pubitemid 27435906)
64. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-229. (Pubitemid 34084323)
65. Fieno D, Kim R, Chen E, Lomasney J, Klocke F, Judd R. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36: 1985-1991.
66. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni E. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
67. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98: 1006-1014. (Pubitemid 28446654)
68. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, Visser CA, van Rossum AC. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003;42:895-901. (Pubitemid 37059750)
69. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-1107. (Pubitemid 32830391)
70. Ingkanisorn W, Rhoads K, Aletras A, Kellman P, Arai A. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-2259. (Pubitemid 38757594)
71. Gutberlet M, Frohlich M, Mehl S, Amthauer H, Hausmann H, Meyer R, Siniawski H, Ruf J, Plotkin M, Denecke T, Schnackenburg B, Hetzer R, Felix R. Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, enddiastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Eur Radiol 2005;15:872-880. (Pubitemid 41166718)
72. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-167. (Pubitemid 34084313)
73. Knuesel PR, Nanz D, Wyss C, Buechi M, Kaufmann PA, von Schulthess GK, Luscher TF, Schwitter J. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003;108:1095-1100. (Pubitemid 37071520)
74. Kuhl H, Beek A, van der Weerdt A, Hofman M, Visser C, Lammertsma A, Heussen N, Visser F, van Rossum A. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomograph. J Am Coll Cardiol 2003;41:1341-1348. (Pubitemid 36442708)
75. Kim RJ, Albert T, Wible J, Elliott MD, Allen JM, Lee J, Parker M, Napoli A, Judd R. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008; 117:629-637.
76. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak J, Butter C, Grip L, Hansen P, Süselbeck T, Clemmensen P, Marin-Galiano M, Geudelin B, Buser P, Investigators ftF. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2009;53:720-729.
77. Aletras A, Tilak G, Natanzon A, Hsu L-Y, Gonzalez F, Hoyt RJ, Arai A. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865-1870. (Pubitemid 43739398)
78. Giri S, Chung Y, Merchant A, Mihai G, Rajagopalan S, Raman S, Simonetti O. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11:56.
79. Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese F, Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J, Agati L. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2009;54:2145-2153.
80. Eitel I, Desch S, Fuernau G, Hildebrand L, Gutberlet M, Schuler G, Thiele H. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010;55:2470-2479.
81. Lotan C, Bouchard A, Cranney G, Bishop S, Pohost G. Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T. Circulation 1992;86:1918-1025.
82. Basso C, Corbetti F, Silva C, Abudureheman A, Lacognata C, Cacciavillani L, Tarantini G, Marra M, Ramondo A, Thiene G, Iliceto S. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol 2007;100:1322-1327. (Pubitemid 47498288)
83. O'Regan D, Ahmed R, Karunanithy N, Neuwirth C, Tan Y, Durighel G, Hajnal J, Nadra I, Corbett S, Cook S. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. Radiology 2009;250:916-922.
84. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, Bogaert J. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009;30:1440-1449.
85. Forest R, Shofer F, Sease K, Hollander J. Assessment of the standardized reporting guidelines ECG classification system: the presenting ECG predicts 30-day outcomes. Ann Emerg Med 2004;44:206-212. (Pubitemid 39144369)
86. GiblerW, Cannon C, Blomkalns A, Char D, Drew B, Hollander J, Jaffe A, Jesse R, Newby L, Ohman E, Peterson ED, Pollak C. Practical implementation of the guidelines for unstable angina/non-ST segment elevation myocardial infarction in the emergency department. Circulation 2005;111:2699-2710.
87. Bassand J-P, Hamm C, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox K, Hasdai D, Ohman E, Wallentin L, Wijns W. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-1660. (Pubitemid 47227122)
88. Kwong R, Schussheim A, Rekhraj S, Aletras A, Geller NL, Davis J, Christian T, Balaban R, Arai A. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003;107:531-537. (Pubitemid 36176800)
89. Cury R, Shash K, Nagurney J, Rosito G, Shapiro M, Nomura C, Abbara S, Bamberg F, Ferencik M, Schmidt E, Brown D, Hoffmann U, Brady T. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation 2008; 118:837-844.
90. Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK, Paterson DI, Syed MA, Aletras AH, Arai AE. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006;47:1427-1432.
91. Plein S, Greenwood J, Ridgeway J, Cranny G, Ball SG, Sivananthan M. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;44:2173-2181. (Pubitemid 39576037)
92. Miller C, Hwang W, Hoekstra J, Case D, Lefebvre C, Blumstein H, Hiestand B, Diercks D, Hamilton CA, Harper E, Hundley WG. Stress cardiac magnetic resonance imaging with observation unit care reduces cost for patients with emergent chest pain: a randomized trial. Ann Emerg Med 2010;56:209-219.
93. Assomull R, Prasad S, Lyne J, Smith G, Burman E, Khan M, Sheppard M, Poole-Wilson P, Pennell D. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2005;48:1977-1985.
94. Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG, Faraggi M. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 2005;237:75-82. (Pubitemid 41346148)
95. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-1590. (Pubitemid 44547428)
96. Haghi D, Fluechter S, Suselbeck T, Kaden J, Borggrefe M, Papavassiliu T. Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy). Int J Cardiol 2007;120:205-211. (Pubitemid 47042254)
97. Mitchell J, Hadden T, Wilson J, Achari A, Muthupillai R, Flamm S. Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome). Am J Cardiol 2007;100:296-301. (Pubitemid 47041991)
98. Rolf A, Nef H, Moellmann H, Troidl C, Voss S, Conradi G, Rixe J, Steiger H, Beiring K, Hamm C, Dill T. Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J 2009; 30:1635-1642.
99. Eitel I, Lucke C, Grothoff M, Sareban M, Schuler G, Thiele H, Gutberlet M. Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eur Radiol 2010;20:422-431.
100. Schwitter J. MRI and MRA of the thoracic aorta. Appl Radiol 2006;Suppl. May: 6-13.
101. Levitt M, Promes S, Bullock S, Disano M, Young G, Gee G, Peaslee D. Combined cardiac marker approach with adjunct two-dimensional echocardiography to diagnose acute myocardial infarction in the emergency department. Ann Emerg Med 1996;27:1-7. (Pubitemid 26021313)
102. Kontos M, Arrowood J, Paulsen W, Nixon J. Early echocardiography can predict cardiac events in emergency department patients with chest pain. Ann Emerg Med 1998;31:550-557. (Pubitemid 28227961)
103. Kaul S, Senior R, Firschke C, Wang X, Lindner J, Villanueva F, Firozan S, Kontos M, Taylor AJ, Nixon I, Watson D, Harrell F. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study. Am Heart J 2004;148:129-136. (Pubitemid 38900492)
104. Udelson J, Beshansky J, Ballin D, Feldman J, Griffith J, Heller GV, Hendel RC, Pope J, Ruthazer R, Spiegler E, Woolard R, Handler J, Selker H. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia. JAMA 2002;288:2693-2700. (Pubitemid 35403782)
105. Bluemke DA, Achenbach S, Budoff M, Gerber T, Gersh B, Hillis L, Hundley WG, Manning WJ, Printz B, Stuber M, Woodard PK. noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation 2008;118:586-606.
106. White C, Kuo D, Kelemen M, Jain V, Musk A, Zaidi E, Read K, Sliker C, Prasad R. Chest pain evaluation in the emergency department: can MDCT provide a comprehensive evaluation? Am J Roentgenol 2005;185:533-540.
107. Hoffmann U, Nagurney J, Moselewski F, Pena A, Ferencik M, Chae C, Cury R, Butler J, Abbara S, Brown D, Manini A, Nichols J, Achenbach S, Brady T. Coronary multidetector computed tomography in the assessment of patients with acute chest pain. Circulation 2006;114:2251-2260. (Pubitemid 44801488)
108. Hoffmann U, Bamberg F, Chae C, Nichols J, Rogers I, Seneviratne S, Truong Q, Cury R, Abbara S, Shapiro M, Moloo J, Butler J, Ferencik M, Lee H, Jang I, Parry B, Brown D, Udelson J, Achenbach S, Brady T, Nagurney J. Coronary computed tomography angiography for early triage of patients with acute chest pain. J Am Coll Cardiol 2009;53:1642-1650.
109. Goldstein J, Gallagher M, O'Neill W, Ross M, O'Neil B, Raff G. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 2007;49:863-871. (Pubitemid 46275355)
110. Hollander J, Chang A, Shofer F, McCusker C, Baxt W, Litt H. Coronary computed tomographic angiography for rapid discharge of low-risk patients with potential acute coronary syndromes. Ann Emerg Med 2009;53:295-304.
111. Rubinshtein R, Halon D, Gaspar T, Jaffe R, Karkabi B, Flugelman M, Kogan A, Shapira R, Peled N, Lewis B. Usefulness of 64-slice cardiac computed tomographic angiography for diagnosing acute coronary syndromes and predicting clinical outcome in emergency department patients with chest pain of uncertain origin. Circulation 2007;115:1762-1768. (Pubitemid 46648613)
112. Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993;22:1804-1808. (Pubitemid 23359635)
113. Wackers F, Lie K, Liem K, Sokole E, Samson G, van der Schoot J, Durrer D. Potential value of thallium-201 scintigraphy as a means of selecting patients for the coronary care unit. Br Heart J 1979;41:111-117. (Pubitemid 9106752)
114. Hilton T, Thompson R, Williams H, Saylors R, Fulmer H, Stowers S. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994;23:1016-1022. (Pubitemid 24117129)
115. Tatum J, Jesse R, Kontos M, Nicholson C, Schmidt K, Roberts C, Ornato J. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997;29:116-125. (Pubitemid 27030027)
116. Kontos M, Jesse R, Schmidt K, Ornato J, Tatum J. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol 1997;30:976-982. (Pubitemid 27435890)
117. Heller GV, Stowerd S, Hendel RC, Herman S, Daher E, Ahlberg A, Baron J, Mendes de Leon C, Rizzo J, Wackers F. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998;31:1011-1017. (Pubitemid 28212500)
118. Kontos M, Jesse R, Anderson F, Schmidt K, Ornato J, Tatum J. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 1999;99:2073-2078. (Pubitemid 29196788)
119. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343: 1445-1453.
120. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772. (Pubitemid 28135339)
121. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoeher M, Kochs M, Woehrle J, Kestler H. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549-557. (Pubitemid 40461096)
122. Nijveldt R, Beek A, Hirsch A, Stoel M, Hofman M, Umans V, Algra P, Twisk J, van Rossum A. Functional recovery after acute myocardial infarction: a comparison between angiography, electrocardiography and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008;52:181-189. (Pubitemid 351915778)
123. Ypenburg C, Schalij M, Bleeker G, Steendijk P, Boersma E, Dibbets-Schneider P, Stokkel M, van der Wall E, Bax J. Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J Nuc Med 2006;47:1565-1570. (Pubitemid 47545018)
124. Rutz AK, Manka R, Kozerke S, Roas S, Boesiger P, Schwitter J. Left ventricular dyssynchrony in patients with left bundle branch block and patients after myocardial infarction: integration of mechanics and viability by cardiac magnetic resonance. Eur Heart J 2009;30:2117-2127.
125. Mollet N, Dymarkowski S, Volders W, Wathiong J, Herbots L, Rademakers F, Bogaert J. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002;106: 2873-2876. (Pubitemid 35424733)
126. Srichai M, Junor C, Rodriguez L, Stillman AE, Grimm R, Lieber M, Weaver J, Smedira N, White R. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006;152:75-84. (Pubitemid 43974727)
127. Weinsaft JW, Kim RJ, Ross M, Krauser D, Manoushagian S, LaBounty TM, Cham MD, Min JK, Healy K, Wang Y, Parker M, Roman MJ, Devereux RB. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC: Cardiovasc Imaging 2009;2:969-979.
128. McCrohon J, Moon J, Prasad S, McKenna W, Lorenz C, Coats A, Pennell D. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59. (Pubitemid 36859020)
129. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-1258. (Pubitemid 38379570)
130. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, Schuler WO, Barkhausen J. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Am J Roentgenol 2005;184:1420-1426. (Pubitemid 43821809)
131. Ingkanisorn WP, Paterson DI, Calvo KR, Rosing DR, Schwartzentruber DJ, Fuisz AR, Arai AE. Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis. J Cardiovasc Magn Reson 2006;8:353-360.
132. De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, Canu T, Perseghin G, Gaudio C, Maseri A, Frustaci A, Del Maschio A. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 2006;47:1649-1654.
133. Gutberlet M, Spors B, Thoma T, Bertram H, Denecke T, Felix R, Noutsias M, Schultheiss HP, Kuhl U. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008;246:401-409.
134. Baccouche H, Mahrholdt H, Meinhardt G, Merher R, Voehringer M, Hill S, Klingel K, Kandol R, Sechtem U, Yilmaz A. Diagnostic synergy of noninvasive cardiovascular magnetic resonance and invasive endomyocardial biopsies in troponinpositive patients without coronary artery disease. Eur Heart J 2009;30:2869-2879.
135. Abdel-Aty H, Boye P, Zagrosek A,Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-1822. (Pubitemid 40779862)
136. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast-media enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1648.
137. Syed I, Glockner J, Feng D, Martinez M, Oh J, Tajik A, Dispenzieri A, Gertz M, Araoz A, Grogan M. Cardiac magnetic resonance imaging for cardiac amyloidosis: analysis of myocardial and blood pool nulling is more sensitive than delayed enhancement. J Am Coll Cardiol 2008;51(Suppl. A):A162.
138. Maceira A, Joshi J, Prasad S, Moon J, Perugini E, Harding I, Sheppard M, Poole-Wilson P, Hawkins P, Pennell D. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:122-124.
139. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert E, Greulich S, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance in clinically 48 suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51:1022-1030. (Pubitemid 351318125)
140. Modell B, Khan M, Darlison M, Westwood M, Ingram D, Pennell D. Improved survival of thalassemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:42.
141. Kirk P, Roughton M, Porter JJ, Tanner M, Patel J, Wu D, Taylor JL,Westwood M, Anderson L, Pennell D. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120:1961-1968.
142. Roguin A, Schwitter J, Vahlhaus V, Lombardi M, Brugada J, Vardas P, Auricchio A, Priori S, Sommer T. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-743.
143. Syed MA, Carlson K, Murphy M, Ingkanisorn WP, Rhoads KL, Arai AE. Longterm safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging 2006;24: 1056-1061. (Pubitemid 44658243)
144. Tschirch F, Suter K, Froehlich J, Studler U, Nidecker A, Eckhardt B, Beranek-Chiu J, Surber C, Weishaupt D. Multicenter trial: comparison of two different formulations and application systems of low-dose nasal midazolam for routine magnetic resonance imaging of claustrophobic patients. J Magn Reson Imaging 2008;28:866-872.
145. Weinreb J, Abu-Alfa A. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned? J Magn Reson Imaging 2009;30:1236-1239.
146. Cowper S. Nephrogenic fibrosing dermopathy [ICNSFR Website]. 2010. http ://www.icnsfr.org (17 August 2010).
147. Schwitter J. Myocardial perfusion imaging by cardiac magnetic resonance. J Nuc Cardiol 2006;13:841-854. (Pubitemid 44895163)
148. Schwitter J. Extending the frontiers of cardiac magnetic resonance. Circulation 2008;118:109-112.
149. Flö gel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 2008;118:140-148.